Skip to content

Low dose inhaled nitric oxide in patients with acute lung injury

Low dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN53268296
Enrollment
385
Registered
2012-01-31
Start date
1996-03-27
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lung injury Injury, Occupational Diseases, Poisoning Other injuries of lung

Interventions

Inhaled nitric oxide (5ppm) or placebo (nitrogen gas) is delivered with mechanical ventilator breaths until the patient is extubated or for a total of 28 days.

Sponsors

Ohmeda/INO Therapeutics Inc (USA)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Mechanically ventilated patients with acute lung injury 2. Ratio of partial pressure of arterial oxygen (O2) to the fraction of inspired partial pressure of oxygen in arterial blood/fraction of inspired oxygen (Pa02/FiO2) ratio of 250 or less

Exclusion criteria

Exclusion criteria: Sepsis as the cause of the acute lung injury

Design outcomes

Secondary

MeasureTime frame
Pulmonary function including spirometry, lung volumes and diffusion of carbon monoxide evaluated at 6 months

Primary

MeasureTime frame
Days alive and off mechanical ventilation

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 24, 2026